Results 1 -
10
of
24
for
Venetoclax
- Venetoclax is used alone or in combination with obinutuzumab (Gazyva) or rituximab (Rituxan) to treat certain types ... them from being treated with other chemotherapy medications. Venetoclax is in a class of medications called B- ...
- Leukemia/Treatments and Therapies ... Leukemia ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs approved by the FDA ...
- Chronic Lymphocytic Leukemia/Treatments and Therapies ... Chronic Lymphocytic Leukemia ... National Cancer Institute ... Chronic lymphocytic leukemia (CLL) treatment ...
- Chronic Lymphocytic Leukemia/Diagnosis and Tests ... Chronic Lymphocytic Leukemia ... National Cancer Institute ... Chronic lymphocytic leukemia (CLL) treatment can include ...
- Chronic Lymphocytic Leukemia/Treatments and Therapies ... Chronic Lymphocytic Leukemia ... National Cancer Institute ... Chronic lymphocytic leukemia (CLL) treatment ...
- Chronic Lymphocytic Leukemia/Start Here ... Chronic Lymphocytic Leukemia ... National Cancer Institute ... From the National Institutes of Health ... Chronic lymphocytic ...
- A list of cancer drugs approved by the Food and Drug Administration (FDA) for non-Hodgkin lymphoma. The list includes generic names, brand names, and common ...
- Clinical advances, research findings, and NCI programs that are leading to progress in treating leukemia. ... Acute Lymphocytic Leukemia/Statistics and Research
- Treatment Options for Plasma Cell Neoplasms (Including Multiple Myeloma)
(National Cancer Institute)
Treatment of plasma cell neoplasms (including multiple myeloma, monoclonal gammopathy of undetermined significance, and plasmacytoma) includes observation, ... - Treatment Option Overview (Plasma Cell Neoplasms Including Multiple Myeloma)
(National Cancer Institute)
Treatment of plasma cell neoplasms (including multiple myeloma, monoclonal gammopathy of undetermined significance, and plasmacytoma) includes observation, ...